Holen Sie sich die Stockscreener-App
117.09
0.02%
-0.02
Handel nachbörslich:
116.93
-0.16
-0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$117.11
Offen:
$117.24
24-Stunden-Volumen:
9.73M
Relative Volume:
0.74
Marktkapitalisierung:
$289.49B
Einnahmen:
$64.93B
Nettoeinkommen (Verlust:
$18.26B
KGV:
16.09
EPS:
7.2751
Netto-Cashflow:
$12.36B
1W Leistung:
-2.29%
1M Leistung:
-0.05%
6M Leistung:
+39.34%
1J Leistung:
+22.95%
1-Tages-Spanne:
$116.67
$119.00
1-Wochen-Bereich:
$113.82
$120.87
52-Wochen-Spanne:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
117.09 | 289.54B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,001.35 | 900.48B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.71 | 584.62B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
227.01 | 402.17B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
161.59 | 310.63B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
194.99 | 302.33B | 58.80B | 10.24B | 8.98B | 3.2788 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co. (NYSE:MRK) Moves Higher Within S&P 500 Index Amid Gains - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Trading 1.2% HigherTime to Buy? - MarketBeat
Merck’s Oncology Portfolio Strategy Beyond Keytruda - Citeline News & Insights
Zostavax Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
WINTON GROUP Ltd Has $8.72 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lessened by Swiss National Bank - MarketBeat
LGT Group Foundation Sells 72,228 Shares of Merck & Co., Inc. $MRK - MarketBeat
LGT Fund Management Co Ltd. Cuts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Russell Investments Group Ltd. Sells 256,688 Shares of Merck & Co., Inc. $MRK - MarketBeat
Vinva Investment Management Ltd Purchases 50,206 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rathbones Group PLC Has $34.35 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Heritage Wealth Advisors Acquires 24,697 Shares of Merck & Co., Inc. $MRK - MarketBeat
Natixis Advisors LLC Has $193.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Korea Investment CORP Sells 198,111 Shares of Merck & Co., Inc. $MRK - MarketBeat
Modern Wealth Management LLC Has $2.83 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat
Blair William & Co. IL Has $68.18 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK): A bull case theory - MSN
Merck & Co., Inc. $MRK Position Trimmed by HUB Investment Partners LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DKRT Investments Corp. - MarketBeat
Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd - MarketBeat
Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA - MarketBeat
Cas and effect: Merck’s phase III ripples HIF-2α space - BioWorld MedTech
Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Dimensional Fund Advisors LP - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.4%Should You Sell? - MarketBeat
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
AI-Powered Tempus Inks New Multi-Year Merck DealTempus AI (NASDAQ:TEM) - Benzinga
Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha
Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Oak Grove Capital LLC Sells 21,515 Shares of Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Advisor Solutions LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Kahn Brothers Group Inc. Sells 56,715 Shares of Merck & Co., Inc. $MRK - MarketBeat
Laurel Wealth Advisors LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.9%Here's What Happened - MarketBeat
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? - Finviz
Merck & Co., Inc. $MRK Position Lifted by Kingsview Wealth Management LLC - MarketBeat
Elo Mutual Pension Insurance Co Has $24.19 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Titan with Strong Buy Ratings and Growth Potential - DirectorsTalk Interviews
Fisher Asset Management LLC Sells 945,571 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Scientists Launch Research Award to Support Rising Chemists of Color - CSRwire
Antibiotics Market - GlobeNewswire Inc.
Davis R M Inc. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK - MarketBeat
River Wealth Advisors LLC Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Rafferty Asset Management LLC - MarketBeat
Quantbot Technologies LP Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bedell Frazier Investment Counselling LLC Sells 34,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Diversify Wealth Management LLC - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):